Preventative Effect of Montelukast in Mild To Moderate Contrast-Induced Acute Kidney Injury in Rats Via Nadph Oxidase 4, P22phox and Nuclear Factor Kappa-B Expressions

dc.contributor.author Simsek, Oguzhan
dc.contributor.author Baris, Elif
dc.contributor.author Ural, Cemre
dc.contributor.author Incir, Canet
dc.contributor.author Aydemir, Selma
dc.contributor.author Gumustekin, Mukaddes
dc.contributor.author Arici, Mualla Aylin
dc.date.accessioned 2025-04-25T19:49:38Z
dc.date.available 2025-04-25T19:49:38Z
dc.date.issued 2025
dc.description Baris, Elif/0000-0001-6838-7932; Simsek, Oguzhan/0000-0003-2756-8440 en_US
dc.description.abstract Reactive oxygen species (ROS) generation, inflammation and apoptosis are observed in contrast-induced acute kidney injury (CI-AKI). NOX4, isoform of NADPH oxidase main regulatory enzyme for ROS generation, is mostly expressed in the kidney and co-localized with p22phox. It is investigated the effect of antioxidant, anti-inflammatory and anti-apoptotic montelukast pre-treatment on expression of NOX4, p22phox and NF-kappa B in preventing CI-AKI in rats in this study. Wistar male rats randomized into four groups: 1. Control (C), 2. CI-AKI (iohexol; 3 g iodine/kg), 3. Montelukast (10 mg/kg) (M), 4. M + CI-AKI. Rats sacrificed on the 7th day. Urine and serum creatinine and serum Kidney injury molecule-1 (KIM-1) levels measured. NF-kappa B, NOX-4, p22phox mRNA and protein expressions, TNF-alpha, KIM-1 mRNA expressions, ROS and caspase-3 evaluated from kidney tissue. Histological injury scored. ANOVA and Kruskal-Wallis tests were used for analysis parametric and nonparametric data, respectively. p < 0.05 considered statistically significant. Tubular injury score, KIM-1 and caspase-3 levels increased in CI-AKI group compared to C group (p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels increased in CI-AKI group compared to C group (p < 0.001 and p < 0.05). NF-kappa B, NOX-4, p22phox protein expressions increased in CI-AKI group compared to C group (p < 0.05) and decreased in the M + CI-AKI group compared to CI-AKI group (p < 0.01, p < 0.05, p < 0.05). TNF-alpha, NF-kappa B, NOX-4, p22phox, KIM-1 mRNA expressions and ROS levels decreased with montelukast pre-treatment (p < 0.001). One of the mechanism of increased ROS level in the CI-AKI model is related the increase the expression of NOX4 and p22phox and montelukast pre-treatment has a protective effect by decreasing NOX4 and p22phox mRNA and protein expressions. en_US
dc.description.sponsorship Dokuz Eylul University Research Foundation [2019.KB.SAG.068] en_US
dc.description.sponsorship This project was supported by Dokuz Eyluel University Research Foundation with the grant number 2019.KB.SAG.068. en_US
dc.identifier.doi 10.1007/s11255-025-04378-5
dc.identifier.issn 0301-1623
dc.identifier.issn 1573-2584
dc.identifier.scopus 2-s2.0-85218711454
dc.identifier.uri https://doi.org/10.1007/s11255-025-04378-5
dc.identifier.uri https://hdl.handle.net/20.500.14365/6047
dc.language.iso en en_US
dc.publisher Springer en_US
dc.relation.ispartof International Urology and Nephrology
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Contrast-Induced Nephropathy en_US
dc.subject Montelukast en_US
dc.subject Oxidative Stress en_US
dc.subject Nox4 en_US
dc.subject P22Phox en_US
dc.title Preventative Effect of Montelukast in Mild To Moderate Contrast-Induced Acute Kidney Injury in Rats Via Nadph Oxidase 4, P22phox and Nuclear Factor Kappa-B Expressions en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Baris, Elif/0000-0001-6838-7932
gdc.author.id Simsek, Oguzhan/0000-0003-2756-8440
gdc.author.scopusid 57214450798
gdc.author.scopusid 57328351600
gdc.author.scopusid 56804887400
gdc.author.scopusid 57221411184
gdc.author.scopusid 57214692710
gdc.author.scopusid 6508158631
gdc.author.scopusid 24179281500
gdc.author.wosid Arici, Mualla/Aas-9385-2020
gdc.author.wosid Simsek, Oguzhan/Aag-1927-2021
gdc.author.wosid /Q-1679-2019
gdc.author.wosid Cavdar, Zahide/T-7394-2019
gdc.author.wosid Özbal, Seda/Aaa-7762-2020
gdc.author.wosid Baris, Elif/Hpf-4375-2023
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C4
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Simsek, Oguzhan; Baris, Elif] Dokuz Eylul Univ, Grad Sch Hlth Sci, Pharmacol, TR-35040 Izmir, Turkiye; [Baris, Elif] Izmir Univ Econ, Fac Med, Dept Med Pharmacol, TR-35040 Izmir, Turkiye; [Ural, Cemre; Cavdar, Zahide] Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Mol Med, TR-35040 Izmir, Turkiye; [Incir, Canet; Gumustekin, Mukaddes] Dokuz Eylul Univ, Fac Med, Dept Med Pharmacol, TR-35040 Izmir, Turkiye; [Aydemir, Selma] Dokuz Eylul Univ, Grad Sch Hlth Sci Histol & Embryol, TR-35040 Izmir, Turkiye; [Yilmaz, Osman] Dokuz Eylul Univ, Grad Sch Hlth Sci, Dept Lab Anim Sci, TR-35040 Izmir, Turkiye; [Ozbal, Seda] Dokuz Eylul Univ, Fac Med, Dept Histol & Embryol, TR-35340 Izmir, Turkiye; [Arici, Mualla Aylin] Dokuz Eylul Univ, Fac Med, Dept Med Pharmacol, TR-35340 Izmir, Turkiye en_US
gdc.description.endpage 2325
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q2
gdc.description.startpage 2313
gdc.description.volume 57
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q3
gdc.identifier.openalex W4407813312
gdc.identifier.pmid 39982657
gdc.identifier.wos WOS:001428097200001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.impulse 2.0
gdc.oaire.influence 2.534938E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 4.2350274E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration National
gdc.openalex.fwci 5.8297
gdc.openalex.normalizedpercentile 0.96
gdc.openalex.toppercent TOP 10%
gdc.opencitations.count 0
gdc.plumx.crossrefcites 1
gdc.plumx.mendeley 3
gdc.plumx.pubmedcites 1
gdc.plumx.scopuscites 2
gdc.scopus.citedcount 2
gdc.virtual.author Barış, Elif
gdc.wos.citedcount 2
relation.isAuthorOfPublication 71e21c57-4f39-4d2d-8ae5-0c37922b593a
relation.isAuthorOfPublication.latestForDiscovery 71e21c57-4f39-4d2d-8ae5-0c37922b593a
relation.isOrgUnitOfPublication 4cbb0a74-ee1a-438b-b714-b8ef253df94b
relation.isOrgUnitOfPublication fbc53f3e-d1d3-4168-afd8-e42cd20bddd9
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 4cbb0a74-ee1a-438b-b714-b8ef253df94b

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
6047.pdf
Size:
3.45 MB
Format:
Adobe Portable Document Format